Broxmeyer H E, Kim C H
Department of Microbiology/Immunology, Walther Oncology Center, Indiana University School of Medicine, and the Walther Cancer Institute, Indianapolis 46202-5254, USA.
Exp Hematol. 1999 Jul;27(7):1113-23. doi: 10.1016/s0301-472x(99)00045-4.
The field of chemokine biology is a rapidly advancing one, with over 50 chemokines identified that mediate their effects through one or more of 16 different chemokine receptors. Chemokines, originally identified as chemotactic cytokines, manifest a number of functions, including modulation of blood cell production at the level of hematopoietic stem/progenitor cells and the directed movement of these early blood cells. This report reviews chemokines and chemokine/receptor activities mainly in the context of hematopoietic cell regulation and the numerous chemokines that manifest suppressive activity on proliferation of stem/progenitor cells. This is contrasted with the specificity of only a few chemokines for the chemotaxis of these early cells. The large number of chemokines with suppressive activity is hypothesized to reflect the different cell, tissue, and organ sites of production of these chemokines and the need to control stem/progenitor cell proliferation in different organ sites throughout the body.
趋化因子生物学领域发展迅速,已鉴定出50多种趋化因子,它们通过16种不同趋化因子受体中的一种或多种介导其作用。趋化因子最初被鉴定为趋化性细胞因子,具有多种功能,包括在造血干细胞/祖细胞水平调节血细胞生成以及这些早期血细胞的定向移动。本报告主要在造血细胞调节以及众多对干细胞/祖细胞增殖具有抑制活性的趋化因子的背景下,综述趋化因子和趋化因子/受体的活性。这与仅有少数趋化因子对这些早期细胞趋化作用的特异性形成对比。据推测,大量具有抑制活性的趋化因子反映了这些趋化因子产生的不同细胞、组织和器官部位,以及控制全身不同器官部位干细胞/祖细胞增殖的需求。